Clinical Trial Update: Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock [NA]

View source ↗

Summary

Magenta Medical's Magenta Elevate clinical feasibility study for cardiogenic shock is currently recruiting and evaluating the device in patients with cardiogeni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Heart Failure
• Myocardial Infarction

Drugs mentioned

• Magenta Elevate

Snippet

Sponsor: Magenta Medical Ltd. | Conditions: Cardiogenic Shock, Heart Failure | NA | Status: RECRUITING